title: Pseudohypopituitary syndromes.
abstract: In a child with short stature, the finding of normal or elevated GH levels in the presence of low concentrations of IGF-I raises the following possibilities. (1) A modification of the GH molecule, which is still detected by RIA, but inactive biologically. Therefore, an RRA or bioassay for hGH should result in considerably lower GH measurements compared with RIA determinations in the same sample. As both bioassays as well as RRAs are not widely available and are hampered by several difficulties, few children with this presumptive diagnosis have been described. So far, it has not been possible to define a specific molecular defect in one of these patients. (2) Abnormalities of the GH receptor or postreceptor mechanisms lead to a GH insensitivity syndrome. Laron-type dwarfism is usually due to a deletion in the gene for hepatic GH receptors: the serum binding protein for GH is absent. In three additional populations, the Pygmies of Zaire, the little women of Loja in Ecuador and the Mountain Ok people in Papua New Guinea, alterations of GH receptor function have been described. Finally, some reports describe patients with normal or elevated serum levels of both growth hormone and IGF-I in whom resistance to IGF has been implied in the pathogenesis of small stature.
authors.forename: E
authors.initials: E
authors.lastname: Heinze
authors.forename: R W
authors.initials: RW
authors.lastname: Holl
mesh_terms: D001827:Body Height / Q000502:physiology; D004393:Dwarfism, Pituitary / Q000097:blood* / Q000503:physiopathology; D013006:Growth Hormone / Q000097:blood / Q000172:deficiency*; D006801:Humans; D011986:Receptors, Somatotropin / Q000502:physiology; D013577:Syndrome
chemical_list: D011986:Receptors, Somatotropin; D013006:Growth Hormone